News Room

News Releases

Nov. 08, 2019Corporate

Posted Video of Investors Meeting Presentation for Q2 FY2019 (April 1 to September 30, 2019) ／Definitive Agreement for Strategic Alliance with Roivant Sciences [Webcast]
Oct. 31, 2019 (PDF/1,705KB)Corporate

Investors Meeting Presentation for Q2 FY2019 (April 1 to September 30, 2019) ／Definitive Agreement for Strategic Alliance with Roivant Sciences
Oct. 31, 2019 (PDF/1,557KB)Corporate

Press Conference Presentation for Definitive Agreement for Strategic Alliance with Roivant Sciences
Oct. 31, 2019 (PDF/186KB)Corporate

Sumitomo Dainippon Pharma and Roivant Sciences Sign a Definitive Agreement for a Strategic Alliance
Oct. 31, 2019 (PDF/103KB)Corporate

【Joint press release】Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance
Oct. 28, 2019 (PDF/926KB)Finances

Press Conference Presentation for Q2 FY2019 (April 1 to September 30, 2019)
Oct. 28, 2019 (PDF/537KB)Finances

Supplementary Financial Data for the Second Quarter of the Year Ending March 31, 2020
Oct. 28, 2019 (PDF/318KB)Finances

Summary of Consolidated Financial Results for the Second Quarter of the Year Ending March 31, 2020
Oct. 21, 2019 (PDF/177KB)Finances

Sumitomo Dainippon Pharma Announces Revisions to Its Financial Forecasts for the half-year period ending September 30, 2019
Oct. 21, 2019 (PDF/141KB)CSR

Sumitomo Dainippon Pharma Contributes to the Typhoon Hagibis in October 2019 in Japan

Nov. 01, 2019 (PDF/1,557KB)Corporate

Press Conference Presentation for Definitive Agreement for Strategic Alliance with Roivant Sciences
Oct. 28, 2019 (PDF/926KB)Finances

Press Conference Presentation for Q2 FY2019 (April 1 to September 30, 2019)
Dec. 02, 2013 (PDF/414KB)R&D

Presentation material of press conference (Healios and DSP: Alliance for Japanese market-iPS cell technology into practical use-)